# FULVESTRANT

NDC: 70710-1688
Generic name: fulvestrant
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20211214

FDA application: ANDA215234

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1688"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1688
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=994edf79-20a5-4e3a-bb35-c4fe3e65acba